MAGEA11 and prostate cancer: MAGE-A11 is reported as a proto-oncogene, and an increased level is intrudingly associated with many cancer types including lung cancer and prostate cancer, and considered to be potential targets for transcriptional cell cycle control and immunotherapies [29,30].